Loading...
Gene expression study of breast cancer using Welch Satterthwaite t-test, Kaplan-Meier estimator plot and Huber loss robust regression model
Karim, Sajjad Iqbal, Md. Shahid Ahmad, Nesar Ansari, Md. Shahid Mirza, Zeenat Merdad, Adnan Jastaniah, Saddig D.
Karim, Sajjad
Iqbal, Md. Shahid
Ahmad, Nesar
Ansari, Md. Shahid
Mirza, Zeenat
Merdad, Adnan
Jastaniah, Saddig D.
Citations
Altmetric:
Genre
Journal article
Date
2022-11-29
Advisor
Committee member
Department
Biology
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1016/j.jksus.2022.102447
Abstract
Objective: Breast Cancer (BC) is one of the deadliest diseases in women, causing thousands of deaths annually despite the advent of high-throughput genomic platforms in the recent past. Microarray-based gene expression profiling with different statistical methods have been extensively used to understand the disease at the molecular level. We plan to apply Welch Satterthwaite t-test, Kaplan-Meier estimator plot and Huber Loss robust regression model on microarray data to improve the analysis and find biomarkers for future diagnosis, prognosis, and treatment. Methods: We retrieved microarray data (GSE10810 dataset) of 31 breast tumor samples and 27 normal breast samples from Gene Expression Omnibus (GEO, NCBI). Welch Satterthwaite t-test was applied to identify the most statistically significant genes, Huber loss robust regression model was applied to investigate the existing mathematical relations between tumor and control variables, and Kaplan-Meier Plotter was used to confirm their association with overall metastatic relapse-free survival of BC patients. Results: We identified 1837 differentially expressed genes, including 638 overexpressed (COL11A1, KIAA0101, S100P, GJB2, TOP2A, LINC01614, RRM2, INHBA, C15orf48 and CKS2) and 1199 under expressed (LEP, ADIPOQ, PLIN1, PCK1, PCOLCE2, ADH1B, LYVE1, FABP4, ABCA8, and CHRDL1) genes passing the threshold (fold change ± 2 and p value < 0.001). KM analysis revealed 12 out of 20 DEGs (log rank p value < 0.05) as potential prognostic and therapeutic biomarkers. Conclusion: Huber loss robust regression model was found to be one of the best performing algorithms for the mathematical relationship between the control and breast tumor samples with co-relation coefficient of 0.4398 and mean absolute error of 1.069 ± 0.020. In conclusion, with high mathematical confidence, we detected DEGs have high potential to be BC biomarkers using Welch t-test and Kaplan-Meier plot having minimum underlying assumptions.
Description
Citation
Sajjad Karim, Md Shahid Iqbal, Nesar Ahmad, Md Shahid Ansari, Zeenat Mirza, Adnan Merdad, Saddig D. Jastaniah, Sudhir Kumar, Gene expression study of breast cancer using Welch Satterthwaite t-test, Kaplan-Meier estimator plot and Huber loss robust regression model,
Journal of King Saud University - Science, Volume 35, Issue 1, 2023, 102447, ISSN 1018-3647, https://doi.org/10.1016/j.jksus.2022.102447.
Citation to related work
Elsevier
Has part
Journal of King Saud University - Science, Vol. 35, Iss. 1
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu